Trichomonas vaginalis is likely the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million women and men in the U.S. CPS’ Davey Legendre is among the collaborating writers and researchers who have just published Diagnosis and Management of Trichomonas Vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

Davey Legendre, PharmD, MBA, BCPS-AQID serves as Vice President, Clinical Infectious Diseases at CPS®. He earned his PharmD at the University of Louisiana Monroe and completed pharmacy practice and infectious diseases residencies at West Virginia University and University of Mississippi, respectively.

Read the full abstract here, published by Clinical Infectious Diseases: